Mention 3riskfactors ofHCC1 in ...(..%)people stillalive in 4 yearswith STRIDEregimenWhich BCLCclassincluded inthe Himalayastudy?Mention 3 imAEof STRIDEregimen inHimalaya studyORR ofSTRIDEregimenDosage ofTremelimumabin STRIDEregimenWhat's the 2preferred regimenthat recommendas 1st line therapyof uHCC in NCCNguidelines?What'sSTRIDEstandsfor?What's thecomparatorin HimalayaStudyMOA ofTremelimumabAsiansubgroupOSresult?BCLC classthat includedin HimalayastudyHR of 4years OSin STRIDEregimen?Primaryendpoint ofHimalayastudyThe majorityetiology ofHCC inHimalayastudyDosage ofDurvalumabin HimalayastudyPFSSTRIDEregimen inHimalayastudyHow doesDurvalumabworks ?4 year OSSTRIDE(Himalaya)How manyarms arestudied inHIMALAYA ?Explain thedosing &schedule ofSTRIDEregimenWhat are 2classificationssystem that areused todetermine thestage of HCC ?What's thetumor markerthat usuallytested fordiagnosingHCC?Mention 3symptomsof HCCMention 3riskfactors ofHCC1 in ...(..%)people stillalive in 4 yearswith STRIDEregimenWhich BCLCclassincluded inthe Himalayastudy?Mention 3 imAEof STRIDEregimen inHimalaya studyORR ofSTRIDEregimenDosage ofTremelimumabin STRIDEregimenWhat's the 2preferred regimenthat recommendas 1st line therapyof uHCC in NCCNguidelines?What'sSTRIDEstandsfor?What's thecomparatorin HimalayaStudyMOA ofTremelimumabAsiansubgroupOSresult?BCLC classthat includedin HimalayastudyHR of 4years OSin STRIDEregimen?Primaryendpoint ofHimalayastudyThe majorityetiology ofHCC inHimalayastudyDosage ofDurvalumabin HimalayastudyPFSSTRIDEregimen inHimalayastudyHow doesDurvalumabworks ?4 year OSSTRIDE(Himalaya)How manyarms arestudied inHIMALAYA ?Explain thedosing &schedule ofSTRIDEregimenWhat are 2classificationssystem that areused todetermine thestage of HCC ?What's thetumor markerthat usuallytested fordiagnosingHCC?Mention 3symptomsof HCC

BINGO !!! - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Mention 3 risk factors of HCC
  2. 1 in ...(..%) people still alive in 4 years with STRIDE regimen
  3. Which BCLC class included in the Himalaya study?
  4. Mention 3 imAE of STRIDE regimen in Himalaya study
  5. ORR of STRIDE regimen
  6. Dosage of Tremelimumab in STRIDE regimen
  7. What's the 2 preferred regimen that recommend as 1st line therapy of uHCC in NCCN guidelines?
  8. What's STRIDE stands for?
  9. What's the comparator in Himalaya Study
  10. MOA of Tremelimumab
  11. Asian subgroup OS result?
  12. BCLC class that included in Himalaya study
  13. HR of 4 years OS in STRIDE regimen?
  14. Primary endpoint of Himalaya study
  15. The majority etiology of HCC in Himalaya study
  16. Dosage of Durvalumab in Himalaya study
  17. PFS STRIDE regimen in Himalaya study
  18. How does Durvalumab works ?
  19. 4 year OS STRIDE (Himalaya)
  20. How many arms are studied in HIMALAYA ?
  21. Explain the dosing & schedule of STRIDE regimen
  22. What are 2 classifications system that are used to determine the stage of HCC ?
  23. What's the tumor marker that usually tested for diagnosing HCC?
  24. Mention 3 symptoms of HCC